Q1 2026 Holdings
Filed 2026-05-15 | 156 holdings | $362.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco DB Commdy Indx Trck(DBC) | UNIT | 46138B103 | $30.6M | 1,057,238 | 8.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $12.6M | 113,254 | 3.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $8.5M | 26,323 | 2.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.6M | 197,051 | 2.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $7.4M | 146,264 | 2.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.2M | 124,647 | 2.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $6.7M | 69,309 | 1.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $6.0M | 114,307 | 1.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $6.0M | 123,909 | 1.6% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $5.8M | 56,602 | 1.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.6M | 225,139 | 1.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $5.5M | 165,227 | 1.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $5.0M | 131,304 | 1.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $4.9M | 352,085 | 1.4% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $4.7M | 22,397 | 1.3% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $4.3M | 173,595 | 1.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $4.2M | 421,881 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.0M | 24,316 | 1.1% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $3.9M | 22,420 | 1.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $3.9M | 78,911 | 1.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.9M | 58,643 | 1.1% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.8M | 99,744 | 1.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.7M | 441,573 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $3.7M | 52,464 | 1.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $3.7M | 49,560 | 1.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.6M | 193,955 | 1.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.6M | 4,918 | 1.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.6M | 33,852 | 1.0% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $3.5M | 2,019,326 | 1.0% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $3.5M | 185,856 | 1.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $3.5M | 226,546 | 1.0% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $3.5M | 20,437 | 1.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.4M | 615,666 | 0.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.3M | 182,929 | 0.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.0M | 35,761 | 0.8% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $3.0M | 213,212 | 0.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $3.0M | 35,587 | 0.8% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $3.0M | 99,850 | 0.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $2.9M | 181,069 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.9M | 91,931 | 0.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $2.9M | 73,102 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.9M | 49,050 | 0.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.8M | 89,397 | 0.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $2.8M | 69,241 | 0.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $2.8M | 97,866 | 0.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.6M | 134,229 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.6M | 73,189 | 0.7% |
| Alumis Inc(ALMS) | COM | 022307102 | $2.5M | 112,929 | 0.7% |
| Microsoft Corp(MSFT) | COM | 594918104 | $2.4M | 6,457 | 0.7% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $2.4M | 183,037 | 0.7% |